Subscribe To
VACC / Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
VACC News
By GlobeNewsWire
June 21, 2023
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
OXFORD, United Kingdom, June 21, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disc more_horizontal
By GlobeNewsWire
May 20, 2022
Vaccitech to Present at the H.C. Wainwright Global Investment Conference
OXFORD, United Kingdom, May 20, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the disco more_horizontal
By Seeking Alpha
April 3, 2022
Vaccitech: Aiming For A Cure In Chronic Hepatitis B
Vaccitech: Aiming For A Cure In Chronic Hepatitis B more_horizontal